![Phospholipides, sodium glycyrrhizate (Phosphogliv) intravenous 2.5 g - [5 vials]](https://mediscom.com.co/wp-content/uploads/2022/11/Phosphogliv-25g-5.webp "Phosphogliv-25g-5.webp")
Description
Phospholipides, sodium glycyrrhizate (Phosphogliv) Pharmacodynamics
Combined agent. It has hepatoprotective, membrane stabilizing and antiviral effect.
Indications
– Fatty liver degeneration (hepatosis);
– Alcoholic, toxic, including drug-induced liver damage;
– In the treatment of viral hepatitis, cirrhosis and psoriasis.
Contraindications .
– Hypersensitivity to glycyrrhizic acid, phosphatidylcholine or other components of the drug;
– Antiphospholipid syndrome;
– Pregnancy (data on efficacy and safety are insufficient);
– Breast-feeding (data on efficacy and safety are insufficient);
– Childhood under 12 years of age (data about efficacy and safety are insufficient).
Dosage and administration
- Adults and children over 12 years of age.
- Intravenously, dissolving the powder in 10 ml of water for injection.
- Carry out intravenous injection slowly.
- Administer 10 ml daily 2 times a day in the morning and in the evening for 10 days and then switch to oral administration of the drug as capsules. Course duration may be increased upon doctor’s recommendation.
